158
Participants
Start Date
August 31, 2007
Primary Completion Date
January 31, 2009
Study Completion Date
January 31, 2009
Fluoxetine
Once daily oral dispersible tablet 2mg 9mg or 18mg
Placebo
Oral dispersible tablet placebo
Mount Sinai School of Medicine, New York
Long Island Jewish Hospital, Bethpage
Western Psychiatric Institute and Clinic/ Merck Child Outpatient Clinic, Pittsburgh
University of North Carolina, Chapel Hill
Institute for Behavioral Medicine, Smyrna
University of Florida, Department of Psychiatry, Gainesville
Ohio State University, Columbus
Children's Hospital of Michigan, Detroit
AMR-Baber Research Inc., Naperville
Red Oak Psychiatry Associates, Houston
Southwest Autism Research and Resource Centre, Phoenix
Center for Psychiatry and Behavioral Medicine, Las Vegas
University of California Davis, Sacramento
University of Illinois, Chicago
Harvard Medical School, Medford
CRCNJ, Voorhees Township
Seattle Children's Hosptial University of Washington, Seattle
Lead Sponsor
Autism Speaks
OTHER
Neuropharm
INDUSTRY